Recent 8-K filings for PAYS

• August 5, 2026, 4:05 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Paysign reports record Q2 revenue $28.3M (+48%), raises FY2026 outlook

  Revenue $28.25M, up 48.1% YoY; GAAP net income $6.76M ($0.11 EPS) vs $1.39M ($0.02) prior year.

• May 12, 2026, 7:29 PM ET other material materiality 0.00 neutral item 5.07 ◈ Shareholder Votes ×2

  Paysign shareholders elect all seven directors, ratify Baker Tilly as auditor at May 8 meeting

  Each director nominee received >34.8M votes for; Newcomer 37.3M, Triplett 34.9M, others in between.

• May 12, 2026, 4:05 PM ET earnings materiality 0.80 positive item 2.02item 9.01 ◈ Earnings Releases

  Paysign Q1 2026 revenue $28.04M (+50.8% YoY); pharma up 81.9%, net income $5.44M

  Revenue $28.04M, up 50.8% YoY; pharma $15.68M (+81.9%), plasma $11.75M (+24.9%).

• March 24, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases ×2

  Paysign FY2025 revenue $82.0M (+40.5%); guides FY2026 revenue $106.5-110.5M, net income nearly doubles

  Full-year 2025 total revenues $82.0M (up 40.5% YoY); net income $7.55M ($0.13 diluted EPS) vs $3.82M ($0.07) in 2024.

• November 12, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Paysign Q3 revenue $21.6M (+41.6% YoY); raises full-year 2025 guidance

  Q3 2025 revenue $21.6M (+41.6% YoY); net income $2.22M (+54.2% YoY); diluted EPS $0.04 vs $0.03 YoY.

• September 16, 2025, 7:59 PM ET litigation materiality 0.65 neutral item 7.01item 9.01

  Paysign proposes settlement of four derivative actions; court hearing set for Nov 14, 2025

  Settlement resolves four stockholder derivative actions alleging violations of Exchange Act and fiduciary duties.

• August 5, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Paysign Q2 revenue $19.08M (+33%), net income $1.39M (+99%), raises FY2025 guidance

  Q2 revenue $19.08M (+33.1% YoY), net income $1.39M (+99.1%), diluted EPS $0.02; Adj. EBITDA $4.51M (+101.8%), $0.08 per share.

• June 6, 2025, 7:59 PM ET other materiality 0.25 neutral item 4.01item 9.01 ◈ Auditor Changes ×2

  Paysign auditor Moss Adams merges into Baker Tilly; successor appointed

  Moss Adams merged into Baker Tilly US, LLP effective June 3, 2025; Moss Adams resigned as auditor.

• May 13, 2025, 7:59 PM ET other materiality 0.15 neutral item 5.07

  Paysign stockholders elect seven directors, approve say-on-pay, ratify Moss Adams

  All seven director nominees elected with over 31M votes for each; broker non-votes ~626K.

• May 8, 2025, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Paysign Q1 2025 revenue up 41% to $18.6M, net income $2.59M; raises full-year guidance

  Total revenues $18.60M (+41% YoY); net income $2.59M ($0.05 diluted EPS) vs $309K ($0.01) in Q1 2024.

• March 25, 2025, 7:59 PM ET M&A materiality 0.90 positive item 2.02item 3.02item 7.01item 9.01

  Paysign Reports FY2024 Revenue of $58.38M and Acquires Gamma Innovation Assets

  Full-year 2024 total revenues increased 23.5% to $58.38 million, with pharma patient affordability revenue up 214.5%.

• November 5, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Paysign Q3 revenue up 23% to $15.26M; pharma affordability revenue surges 219%

  Total revenues $15.26M (+23% YoY); net income $1.44M ($0.03 diluted EPS) vs $1.10M ($0.02) prior year.

• July 31, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Paysign Q2 2024 revenue up 29.8% to $14.33M; raises full-year guidance

  Net income of $697K ($0.01 diluted EPS) vs net loss of $104K in Q2 2023.

• May 7, 2024, 7:59 PM ET other material materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×2

  PaySign annual meeting elects directors and ratifies auditor for FY2024

  All seven director nominees elected; Mark R. Newcomer received 33.88M votes for, Jeffrey B. Newman 31.26M.

• May 7, 2024, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01 ◈ Earnings Releases

  Paysign Q1 revenue $13.2M (+30% YoY); net income $309k vs loss; reaffirms FY guidance

  Total revenue $13.2M, up 30% YoY; net income $309k ($0.01 diluted EPS) vs net loss $160k in Q1 2023.

• April 19, 2024, 7:59 PM ET litigation materiality 0.65 neutral item 8.01

  Court approves $3.75M settlement of Paysign securities class action; claims dismissed

  U.S. District Court for Nevada granted final approval of settlement on April 17, 2024.

• March 26, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Paysign FY2023 revenue up 24% to $47.3M; net income $6.5M; guides FY2024 revenue $54.5-56.7M

  Full-year 2023 total revenue $47.3M (+24% YoY); net income $6.5M ($0.12 diluted EPS) vs $1.0M ($0.02) in 2022.

• March 15, 2024, 7:59 PM ET other materiality 0.15 neutral item 5.03item 9.01 ◈ Governance Changes

  Paysign amends bylaws to add Chief Legal Officer role and reflect company name change

  Board approved Second Amended and Restated Bylaws on March 14, 2024.

• January 29, 2024, 6:59 PM ET leadership materiality 0.50 neutral item 5.02 ◈ executive_change ×3

  Paysign appoints Cambi as COO, Lanford as Chief Payments Officer, Newcomer as President

  Cosimo Cambi appointed COO effective Jan 24, 2024, succeeding Matt Lanford.

• November 7, 2023, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Paysign Q3 revenue up 17% to $12.4M; net income $1.1M; pharma revenue +142%

  Q3 total revenues $12.4M (+17% YoY); net income $1.1M, diluted EPS $0.02.

• August 8, 2023, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01 ◈ Earnings Releases

  Paysign Q2 revenue up 28% to $11.0M; Adjusted EBITDA $1.1M; guides FY rev $44-46M

  Revenue $11.0M, up 28% YoY; net loss $0.1M ($0.00 EPS).

• May 10, 2023, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 9.01 ◈ Earnings Releases

  Paysign Q1 rev +23% to $10.1M, net loss narrows; Q2 guidance calls for continued growth

  Q1 2023 revenues $10.1M (+23% YoY); net loss $0.2M improved from $0.3M loss a year ago.

• May 9, 2023, 7:59 PM ET other materiality 0.45 neutral item 5.02item 5.07item 9.01 ◈ Shareholder Votes ×3

  Paysign shareholders approve 2023 Equity Incentive Plan with 5M shares; all director nominees elected

  2023 Plan approved with ~32.97M for, 0.79M against; replaces 3Pea 2018 plan; 5M shares reserved.

• March 28, 2023, 7:59 PM ET other material materiality 0.40 neutral item 1.01item 9.01 ◈ Material Agreements

  Paysign repurchases 200K shares from former director at ~$666K, 90% of VWAP

  Repurchased 200,000 shares from former director Daniel Spence at 90% of 10-day VWAP; total price $666,018.

• March 22, 2023, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01 ◈ Earnings Releases ×2

  Paysign reports FY2022 revenue $38.0M (+29% YoY), net income $1.0M; guides FY2023 revenue $44-46M

  Full-year 2022 revenue $38.0M, up 29% YoY; net income $1.0M ($0.02 diluted EPS) vs net loss of $2.7M in 2021.

• March 22, 2023, 7:59 PM ET other material materiality 0.50 positive item 7.01item 9.01

  Paysign authorizes $5M stock repurchase program, to run 36 months

  Board authorized repurchase of up to $5,000,000 of outstanding common stock.

• February 27, 2023, 6:59 PM ET other materiality 0.10 neutral item 5.08

  Paysign sets 2023 annual meeting for May 5; proposal deadline March 10

  2023 Annual Meeting scheduled for May 5, 2023; record date March 24, 2023.

• December 22, 2022, 6:59 PM ET other materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×2

  Paysign shareholders elect all seven director nominees and ratify auditor at annual meeting.

  Mark R. Newcomer elected with 34,398,763.57 For, 18,677.06 Withheld, 1,834,965 Broker Non-Votes.

• November 8, 2022, 6:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01 ◈ Earnings Releases

  Paysign Q3 2022 revenue $10.6M (+36% YoY); net income $0.85M; guides FY2022 rev $38.15-38.35M

  Revenue $10.6M (+36% YoY); net income $0.85M vs loss of $0.27M in Q3 2021; diluted EPS $0.02.

• October 18, 2022, 7:59 PM ET other material materiality 0.20 neutral item 5.08

  Paysign reschedules 2022 Annual Meeting to Dec 16, updates proposal deadlines

  Annual Meeting moved from Oct 28 to Dec 16, 2022; record date set as Oct 21, 2022.

• September 2, 2022, 7:59 PM ET other materiality 0.20 neutral item 5.08

  Paysign sets 2022 annual meeting for Oct 28, 2022; stockholder proposal deadline Sept 12, 2021 per filing

  Annual meeting will be held on October 28, 2022; record date is August 31, 2022.

• August 9, 2022, 7:59 PM ET leadership materiality 0.40 neutral item 5.02item 7.01item 9.01 ◈ executive_change ×2

  Paysign board member Daniel Spence resigns; President Matt Lanford appointed

  Daniel H. Spence, co-founder, resigned from board effective Aug 8, 2022; no disagreement with company.

• August 9, 2022, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  Paysign Q2 revenue $8.6M (+29% YoY); net loss narrows to $0.2M; adds 62 plasma centers

  Revenue $8.6M, up 29% YoY; net loss $0.2M vs $0.7M loss last year; adjusted EBITDA $0.9M.

• August 3, 2022, 7:59 PM ET other material materiality 0.50 neutral item 4.01

  Paysign appoints Moss Adams LLP as independent auditor for FY2022

  Audit committee selected Moss Adams LLP after competitive process; effective June 11, 2022.

• May 11, 2022, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 9.01

  Paysign Q1 revenue $8.2M (+31% YoY), net loss $0.3M; reaffirms FY2022 guidance

  Revenue $8.2M vs $6.3M in Q1 2021; net loss $0.3M (($0.01) per share).

• April 8, 2022, 7:59 PM ET other material materiality 0.50 neutral item 4.01item 9.01

  Paysign's auditor BDO USA resigns; no disagreements reported

  Auditor BDO USA, LLP resigned effective upon filing of Q1 2022 Form 10-Q.

• March 22, 2022, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  Paysign Q4 2021 rev $8.8M, net income $0.1M; FY22 guidance rev $35.3-38.4M

  Q4 total rev $8.8M (+21% YoY); net income $0.1M vs loss; adj EBITDA $1.3M.

• November 9, 2021, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Paysign Q3 revenue $7.8M; plasma $7.0M (+35.6% YoY); net loss $0.3M; raises adj. EBITDA guidance to $1.3-1.9M

  Total revenue $7.8M for Q3 2021, up $1.1M (16.8%) from Q2 2021 and $7.9M from year-ago.

• October 6, 2021, 7:59 PM ET leadership materiality 0.50 neutral item 5.02 ◈ executive_change

  Paysign EVP Daniel H. Spence departs effective Sept 30; remains advisor and board member

  Employment of EVP Daniel H. Spence ended September 30, 2021.

• August 10, 2021, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 9.01

  Paysign Q2 2021 revenue $6.7M (+3.2% YoY); net loss $0.9M; raises adjusted EBITDA guidance

  Q2 revenue $6.7M (+3.2% YoY); net loss $0.9M (($0.02) diluted EPS).

• August 9, 2021, 7:59 PM ET other materiality 0.15 neutral item 5.07

  PaySign stockholders elect all seven director nominees; BDO USA ratified as auditor

  All seven director nominees elected with substantial votes; highest total 33.8M for Bruce Mina and Dennis Triplett.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.90 · Median 0.65 · Most common event earnings

19 positive 0 negative 22 neutral

source · PAYS on sec.gov